# SmartTools Batch 15 Report — Tool 111 parity for Tool 140

Date: 2026-10-24

Status: `IMPLEMENTED — focused engine and DOM tests, catalog/route checks, TypeScript and targeted ESLint pass.`

## Audit and scope

- Audited catalog tools 137–142 against their descriptions, existing files, routes and registry entries. The six identities were already in catalog 10; none had an implementation at the start of the batch.
- Tool 140's description specifies laboratory result units, despite “Dosage” in the identity. Implemented it as an analyte-specific lab result unit converter and preserved the existing ID and slug. It does not convert medication doses or interpret results.
- Tools 137, 138, 139, 141 and 142 concern injectable reconstitution/formulation, solvent proportions, injection pressure, and active yield. They remain planned pending a separate evidence and safety review.
- Factors and assay/specimen limits are recorded in `docs/SMARTTOOLS_UNIT_CONVERSION_SOURCES.md`, using the published Labcorp and Mayo Clinic Laboratories conversion tables.

## Implementation

- Added a deterministic V6 engine and typed Zod schema for 15 exact analyte/unit pairs. Forward conversion multiplies by the published factor; reverse conversion divides by it. The schema rejects unsupported pairs and values outside finite, nonnegative bounds.
- Added an Arabic/English RTL/LTR form with a blank initial value, explicit calculate/reset, stale-result clearing, displayed direction/factor/source, and direct reference links.
- Added the ToolOutput adapter with registry identity, result/formula/source findings, scope notice and unassessed provenance.
- Added canonical pharmacokinetics route and flat redirect; registered the identity and changed the catalog status/title to describe laboratory-result conversion.
- Updated the shared method label, parity roadmap and 252 inventory. Tool 140 moves from planned/missing to targeted tests pass; identity count remains 166.

## Verification

| Check | Status | Evidence |
|---|---|---|
| Tool 140 engine and DOM tests | `PASS` | `npx vitest run lib/tools/engines/tool-140-dosage-unit-conversion-engine.v6.test.ts components/tools/tool-140-dosage-unit-conversion-engine.test.tsx` — 8 tests across 2 files. |
| Catalog validation, registry and legacy routes | `PASS` | `npx vitest run tests/unit/validateTools.test.ts lib/tools/registry.test.ts lib/legacy-routes.test.ts` — 41 tests across 3 files. |
| TypeScript | `PASS` | `npx tsc --noEmit` — exit 0. |
| Targeted ESLint | `PASS` | Changed runtime files — exit 0. |
| Production build | `PASS` | `npm run build` — Next.js compiled, type-checked and generated 373/373 static pages. Existing stale Browserslist and missing `metadataBase` warnings remain. |
| Browser/manual accessibility review | `NOT RUN` | DOM tests do not verify real-browser interaction, keyboard-only use, contrast or screen-reader behavior. |
| Live Supabase/RLS | `NOT RUN` | No production database access or changes. |

## Limits and continuation

- Published factors are rounded and may produce small conversion differences. A converted value does not establish assay interchangeability, reference range or clinical meaning.
- Tools 137–139 and 141–142 remain planned and are not counted as implemented.
- Continue with tools 143–150 after auditing their source descriptions, dependencies and safety scope; keep applying the Tool 111 checklist only where each domain supports it.
- No database writes, migrations, commits, pushes or deployment were performed.
